Company
Headquarters: Taoyuan City, Taiwan
TW$28.98 Billion
TWD as of Jan. 1, 2025
US$882.9 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $216.79 B |
| EssilorLuxottica SA | $116.96 B |
| Becton, Dickinson and Company | $69.74 B |
| HOYA Corp | $45.26 B |
| Alcon Inc. | $41.55 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. The company was incorporated in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation is a subsidiary of Pegatron Corp.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | TW$7.06 B |
| EBITDA | TW$3.13 B |
| Gross Profit TTM | TW$4.02 B |
| Profit Margin | 28.27% |
| Operating Margin | 28.31% |
| Quarterly Revenue Growth | -1.10% |
Pegavision Corp has the following listings and related stock indices.
Stock: TWSE: 6491 wb_incandescent